TrialJournal of neurovirology2012

Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy.

Torsak Bunupuradah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.